Pharmaceutical Proteomics
A special issue of Proteomes (ISSN 2227-7382).
Deadline for manuscript submissions: closed (15 September 2018) | Viewed by 5397
Special Issue Editor
Interests: quantitative proteomics; pharmaceutics; biotherapeutics; targeted protein quantificaiton; cancer; cardiovascular diseases; chromatography; high-resolution MS
Special Issue Information
Dear Colleagues,
With the tremendous advances in chromatographic, mass spectrometric, and informatics techniques, proteomics has become a highly valuable tool in pharmaceutical investigation. The last decade has witnessed rapidly increasing applications of proteomics—both quantitatively and qualitatively—in characterizing drug mechanisms of action, safety, efficacy, off-target effects, pharmacodynamics, etc. Such works have not only greatly extended our understanding of the biology, pharmacology, and pharmaceutics of existing therapeutic agents, but have also provided novel insights into the discovery and development of new candidates.
This Special Issue encompasses a broad range of works employing proteomics methods to answer pharmaceutical or related questions.
Prof. Dr. Jun QuGuest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Proteomes is an international peer-reviewed open access quarterly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1800 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- pharmaceutical investigation
- drug effects
- safety
- efficacy
- mechanisms of action
- time courses
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
